Irish multinational group APC and VLE Therapeutics reveals €100m expansion.
More than 300 new jobs are to be created as part of a €100m investment in The Medicine Accelerator Campus in Dublin, which aims to transform how medicines are researched, digitised and manufactured.
The business is currently working on more than 35 medicines that transform patient treatment in areas such as oncology, respiratory disease, Alzheimer’s, HIV and more.
“As an Irish multinational company, it also solidifies our confidence in the biopharma ecosystem in Ireland as a global hub”
The 130,000 sq ft campus, the largest R&D site in the biopharma sector in Ireland and the expanded home for APC which focuses on R&D and VLE which focuses on manufacturing, will integrate the latest developments in scientific research, AI, neural networks and scientifically led manufacturing activities.
This value chain is transforming medicine development and the time to patient for new and advanced therapeutics.
An impactful Irish multinational
The group, which is fully Irish owned, is already the largest employer of R&D scientists, within the pharmaceutical sector, nationally. This addition of 300 new roles will bring the combined team to over 600 scientists, digital experts, and manufacturing professionals bringing The Medicine Accelerator team to a global stage.
“Reimagining how medicines are developed and accelerated to patients is our motivation, our purpose. Today’s announcement of an additional 300 new jobs, along with a €100m capital plan to create a new 130,000 square foot Medicine Accelerator Campus in Cherrywood, Dublin, demonstrates our confidence in our team to deliver on that purpose,” said APC co-founder and CEO Mark Barrett.
“We are 100% behind them, they are simply extraordinary. As an Irish multinational company, it also solidifies our confidence in the biopharma ecosystem in Ireland as a global hub, one that is trusted and central to medicine supply chains globally, to drive further innovation in the areas of pharmaceutical R&D, digitalisation, and manufacture.
This new expansion will further strengthen our competitiveness through increased integration of the latest developments in sustainability, artificial intelligence, and breakthrough science. It will enable our team to reimagine and transform medicine development and manufacture. I am so excited to see our organisation pursue such a patient focused mission.
The support of Enterprise Ireland has been pivotal in accelerating this expansion and we look forward to continuing to work with them on our mission to accelerate medicines to patients.”
The expansion is being supported by Enterprise Ireland, which welcomed the creation of high value pharma jobs and the strengthening of Ireland’s position in the global value chain of medicine development and manufacturing. The State agency revealed that its client businesses generated more than 15,000 jobs in 2023, including a strong cohort of scaling Irish medtech and life sciences businesses.
“Enterprise Ireland is proud to support the ambitious vision behind APC & VLE’s groundbreaking Medicine Accelerator Campus announced today,” said CEO Leo Clancy.
“The Campus will further enhance Ireland’s global reputation as a leader in the Life Sciences sector and I want to congratulate the entire team at APC and VLE on delivering on this remarkable project.
“One of Enterprise Ireland’s core priorities is to assist Irish owned companies to scale internationally, while creating high-value jobs at home. Today’s announcement is a concrete example of how this can be achieved and we look forward to continuing to work closely with APC and VLE as they implement their ambitious strategy and delivering innovative health solutions to a global market.”
The expansion was welcomed by Minister for Enterprise, Trade and Employment Simon Coveney, TD, who said: “The government through Enterprise Ireland is committed to scaling and building globally impactful Irish multinationals that will help drive the Irish economy forward and create high value jobs at home. APC and VLE’s announcement today is testament to that Irish multinational ambition in action and I am delighted to support them on their patient-focused mission.”
Main image at top: Enterprise Ireland CEO Leo Clancy with APC and VLE group CEO Mark Barrett